Non-segmental Vitiligo Clinical Trials

7 recruiting

Non-segmental Vitiligo Trials at a Glance

10 actively recruiting trials for non-segmental vitiligo are listed on ClinicalTrialsFinder across 6 cities in 24 countries. The largest study group is Phase 2 with 7 trials, with the heaviest enrollment activity in The Bronx, Troy, and Indianapolis. Lead sponsors running non-segmental vitiligo studies include CSPC Ouyi Pharmaceutical Co., Ltd., Derm Texas, PLLC, and AbbVie.

Browse non-segmental vitiligo trials by phase

Treatments under study

About Non-segmental Vitiligo Clinical Trials

Looking for clinical trials for Non-segmental Vitiligo? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Non-segmental Vitiligo trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Non-segmental Vitiligo clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Phase 2

A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo

Non-segmental Vitiligo
Novartis Pharmaceuticals210 enrolled15 locationsNCT07431177
Recruiting
Phase 1

Study to Evaluate the Safety, Tolerability and How IBI3013 is Taken up and Processed by the Body in Healthy Volunteers After Single-dose Administration, and in Non-segmental Vitiligo Patients and Alopecia Areata Patients After Multiple-dose Administration

HealthySevere Alopecia AreataActive Non-segmental Vitiligo
Innovent Biologics (Suzhou) Co. Ltd.160 enrolled1 locationNCT07554222
Recruiting
Phase 2

A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo

VitiligoNon-Segmental Vitiligo (NSV)
Eli Lilly and Company60 enrolled35 locationsNCT07533019
Recruiting
Phase 2

Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients

Non-segmental Vitiligo
Elixiron Immunotherapeutics (Hong Kong) Ltd.45 enrolled3 locationsNCT07223229
Recruiting
Phase 2

A Trial of SHR0302 Tablets and SHR0302 Base Gel in Patients With Non-segmental Vitiligo

Non-segmental Vitiligo
Jiangsu HengRui Medicine Co., Ltd.176 enrolled1 locationNCT07251595
Recruiting

A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa

Alopecia AreataHidradenitis SuppurativaNon-Segmental Vitiligo (NSV)
AbbVie2,795 enrolled116 locationsNCT07136467
Recruiting
Phase 2

Efficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental Vitiligo

Non-segmental Vitiligo
Jiangsu vcare pharmaceutical technology co., LTD120 enrolled1 locationNCT07172347
Recruiting
Phase 4

Comparison of Needling and Microneedling Plus Phototherapy in Localized Vitiligo Patients

VitiligoNon-segmental Vitiligo
Khyber Teaching Hospital80 enrolled1 locationNCT06991972
Recruiting
Phase 2

An Open-label Single Center, Proof of Concept Study Evaluating the Efficacy of Roflumilast Foam 0.3% in Pediatric Patients With Non-Segmental Vitiligo (NSV)

Non-segmental Vitiligo
Derm Texas, PLLC20 enrolled1 locationNCT07105254
Recruiting
Phase 2

A Study to Evaluate the Efficacy and Safety of SYHX1901 Tablet in Non-segmental Vitiligo Patients

Non-segmental Vitiligo
CSPC Ouyi Pharmaceutical Co., Ltd.144 enrolled1 locationNCT06511739